Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$1,440.8M | 5.8 | N/A | 15.5% | 17.6% | N/A | (58.8%) | 1,401.6% | N/A | 60.6% | |
$303.8B | 3.6 | 4.4% | 9.5% | 17.5% | (0.9%) | (48.9%) | 137.3% | 10.4% | (20.3%) | |
$267.5B | 8.2 | 17.3% | 8.7% | 8.0% | 94.7% | 51.5% | 73.1% | 27.5% | 30.9% | |
$168.1B | 8.7 | 26.0% | 22.4% | 18.8% | 15.8% | (18.4%) | 136.5% | 30.4% | 25.2% | |
$163.6B | 7.6 | 19.2% | 13.7% | 12.7% | 11.6% | 9.8% | 83.2% | 21.0% | 20.5% | |
$150.8B | 7.5 | 25.5% | 18.0% | 14.6% | N/A | 414.3% | (46.9%) | N/A | 106.8% | |
$120.1B | 8.4 | 41.3% | 25.8% | 22.5% | N/A | 1,278.1% | (4.4%) | 186.9% | 76.4% | |
$85.1B | 6.7 | N/A | 43.4% | 21.4% | N/A | 350.9% | 41.5% | N/A | 98.1% | |
$64.7B | 7.1 | 18.4% | 16.5% | 12.7% | N/A | (62.3%) | 330.8% | 28.7% | 14.7% | |
$63.6B | 5.9 | 14.7% | 13.5% | 11.9% | 1.5% | 0.8% | 72.8% | 11.3% | (10.3%) | |
$54.4B | 5.9 | (1.0%) | (6.6%) | 2.6% | N/A | N/A | (93.6%) | N/A | 1,069.8% |
The Enfusion, Inc. (ENFN) revenue growth is 15.5%, which is lower than the industry median of 11.5% and the 5-year historical average of 58.7%.
The Enfusion, Inc. (ENFN) operating income growth is (48.5%), compared to the industry median of (2.4%) and the 5-year historical average of (41.2%).
The Enfusion, Inc. (ENFN) EPS growth is (58.8%), compared to the industry median of (12.5%) and the 5-year historical average of 5,644.1%.
The Enfusion, Inc. (ENFN) Free Cash Flow growth is 60.6%, compared to the industry median of 31.1% and the 5-year historical average of 99.8%.